bpc-157 fda status compounding pharmacies 2026 Big news for the peptide space. The Pharmacy Advisory Committee recently voted eight to six in favor of allowing compounding to produce BPC 157. Here is what you need FDA panel votes to place
FDA panel votes to place popular peptide BPC 157 on compounding list Reuters FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them FDA Peptide Review 2026: What This Big Shift Means BPC 157 FDA Approval Status 2026: Clinical Trials
Pay in 4 interest-free payments of $7.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


